Minoryx Therapeutics
BioTech/Drugs - Mataró, N/A, ES
Minoryx Therapeutics Employees
Minoryx Therapeutics Senior Management
Minoryx Therapeutics Details
Minoryx is a clinical stage biotech company focusing on the development of novel therapies for orphan CNS diseases with high unmet medical needs. The company's lead program, leriglitazone (MIN-102), a novel, selective PPARγ agonist, is currently being evaluated in X-ALD and Friedreich's Ataxia. The company is backed by a syndicate of experienced investors and has support from a network of other organizations. Minoryx was founded in 2011, has operations in Spain and Belgium and has raised a total of €50M through Series A & B financing rounds.
Website:
minoryx.com
Employees:
20 - 49
HQ:
N/A
Location:
Mataró, N/A, ES
Revenue:
Not Available
Minoryx Therapeutics Technologies
Captcha
reCAPTCHA
Email Providers
Outlook
Load Balancers
Nginx
Event Management
Cvent
Tag Management
Google Tag Manager
Analytics and Tracking
Quantcast